A new USC study correlating vascular health with early dementia. One of the therapeutic targets, on Ohm20's list, is Vasculitis (inflammation of the vascular system). The article does not go into the reasons for the decline of vascular health, only to say that it should be a target for possible treatment, and it should be used as an assisting diagnostic step for dementia. Leronlimab should be able to treat vascular health. Blocking CCR5 receptors will reduce any vascular inflammation and improve cellular health.

https://scitechdaily.com/usc-study-exposes-hi...d-vessels/